At-home FIT screening involves testing stool for amounts of blood too small to see, which can help to diagnose colon cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.

JOPLIN, Mo. — More people are using at-home colon screening tests, but health experts say that doesn’t necessarily replace the need for a colonoscopy. The American Cancer Society recommends colorectal ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

(BPT) - Recently, Minnesotans have been receiving unsolicited, unrequested at-home colon cancer screening kits from health insurers, without a doctor's input. If you received one in the mail, you ...

PHILADELPHIA (WPVI) -- Colon cancer screenings are improving slowly, but still lag. Now medical students and young doctors at Temple Health are trying to change that in North Philadelphia. While ...

Colonoscopies are considered the gold standard for detecting colorectal cancer. But some dread the idea of the invasive procedure and the prep required the day before you have it. The FDA last year ...

If the too-good-to-be-true filter in your brain isn’t quite working the way it should, this may sound like the perfect alternative to the often-dreaded colonoscopy — at-home stool sample tests you ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like blood and breath tests, may offer alternatives to in-office screenings.